| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
| 09/23/1999 | WO1999047551A1 Wf14573 or its salt, production thereof and use thereof |
| 09/23/1999 | WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 09/23/1999 | WO1999047151A1 Peptide ligands for the erythropoietin receptor |
| 09/23/1999 | WO1999040112A8 Neuroprotective peptides and uses thereof |
| 09/23/1999 | WO1999040106A3 Use of angiotensin analogues for promoting erythropoiesis |
| 09/23/1999 | WO1999039728A3 Methods of inducing hair growth and coloration |
| 09/22/1999 | EP0943623A1 Cyclic hexapeptide antifungal agents |
| 09/22/1999 | EP0943622A1 Peptide ligands for affinity purification of fibrinogen |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942901A1 Cyclic imines as pesticides |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0756449A4 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| 09/22/1999 | EP0673387B1 Materials and methods for control of pests |
| 09/22/1999 | EP0615522B1 Muramyl compounds for treatment of septic shock |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955573 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 09/21/1999 | US5955433 Method of thrombin inhibition |
| 09/21/1999 | US5955431 Mast cell protease peptide inhibitors |
| 09/21/1999 | US5955430 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 09/21/1999 | US5955426 Such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes |
| 09/21/1999 | US5955421 Peptides containing D-2-alkyl-Tryptophan |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences |
| 09/21/1999 | US5955343 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 09/21/1999 | US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955075 Molecular hybridization, genetic engineering |
| 09/21/1999 | CA2179286C Broad spectrum antimicrobial compounds and methods of use |
| 09/21/1999 | CA2145313C Antimicrobial peptides |
| 09/21/1999 | CA2012867C Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999045954A1 Hla-binding peptides and their uses |
| 09/16/1999 | WO1999045945A1 Improved radiation therapy methods |
| 09/16/1999 | WO1999045944A1 Proapoptotic peptides, dependence polypeptides and methods of use |
| 09/16/1999 | WO1999045941A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2659664A1 Improved radiation therapy methods |
| 09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
| 09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941478A1 Assay method for peptide specific t-cells |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941244A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies |
| 09/15/1999 | EP0941237A1 Cyclic hexapeptides having antibiotic activity |
| 09/15/1999 | EP0941236A1 Cyclohexapeptides having antimicrobial activity |
| 09/15/1999 | EP0941235A1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| 09/15/1999 | EP0941234A1 Preprotachykinin-c gene encoding substance z tachykinin precursor |
| 09/15/1999 | EP0941233A2 Antiviral peptide derivatives |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941120A1 Branched peptide linkers |
| 09/15/1999 | EP0776335A4 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952473 Reagent and kit for determining isoprenylating activity and inhibition thereof |
| 09/14/1999 | US5952469 Murine UCP3 polypeptides |
| 09/14/1999 | US5952464 Oligopeptide with selective neurotensin receptor affinity labelled with metal isotope or radioactive halogen isotope; for diagnostic imaging and anticarcinogenic agents |
| 09/14/1999 | US5952299 Cyclic peptide nuclei and derivatives thereof |
| 09/14/1999 | US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof |
| 09/14/1999 | US5951985 Tumor associated epitope |
| 09/14/1999 | CA1340735C Htlv-iii envelope peptides |
| 09/14/1999 | CA1340732C Sv40 expression vector containing hbxag as an expression marker |
| 09/10/1999 | WO1999045121A1 EPITOPE PEPTIDES IMMUNOGENIC AGAINST $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/10/1999 | WO1999045020A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| 09/10/1999 | WO1999044628A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/10/1999 | CA2326408A1 Epitope peptides immunogenic against streptococcus pneumoniae |
| 09/10/1999 | CA2321171A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | CA2231621A1 Consensus sequence to identify acyltransferase enzymes in plants |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 09/08/1999 | EP0637968B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 09/08/1999 | CN1228121A Method for mass production of antimicrobial peptide |
| 09/07/1999 | US5948889 Purified bacterial cell division protein for screening libraries of compounds |
| 09/07/1999 | US5948884 Cyclic peptide with substituents on the methylene group of sarcosine in position 3 of cyclosporin; viricide against human immunodeficiency virus without immunosuppressive effect |
| 09/07/1999 | US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein |
| 09/07/1999 | US5948761 For treating conditions characterized by high levels of extracellular fluid; human or veterinary medicine |
| 09/07/1999 | US5948755 Cyclosporin compound, its preparation and the pharmaceutical compositions which contain it |
| 09/07/1999 | US5948753 Cyclohexapeptidyl propanolamine compounds |
| 09/07/1999 | US5948693 Solid phase synthesis of immunosuppressive agents |
| 09/07/1999 | CA2026041C Deacetoxycephalosporin c hydroxylase |
| 09/07/1999 | CA1340726C Redox amino acids and peptides containing them |
| 09/02/1999 | WO1999043709A2 Melanocortin receptor antagonists and modulations of melanocortin receptor activity |
| 09/02/1999 | WO1999043700A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/02/1999 | WO1999043699A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/02/1999 | WO1999043357A1 Indolicidin and cationic peptides conjugated with polymers |
| 09/02/1999 | WO1999043337A1 Cyclic peptide antifungal agents |
| 09/02/1999 | CA2321928A1 Cyclic peptide antifungal agents |
| 09/02/1999 | CA2321114A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938497A1 Constrained helical peptides and methods of making same |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |